{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:27:36Z","timestamp":1782170856568,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00277-024-06114-y","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T02:03:48Z","timestamp":1732673028000},"page":"5599-5605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recurrent PAX5::ZCCHC7 rearrangement in B-cell acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"103","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haigang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"6114_CR1","doi-asserted-by":"crossref","unstructured":"Fouad FM, Eid JI (2023) PAX5 fusion genes in acute lymphoblastic leukemia: a literature review. Medicine; 102","DOI":"10.1097\/MD.0000000000033836"},{"key":"6114_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/leu.2008.306","volume":"23","author":"K Nebral","year":"2008","unstructured":"Nebral K, Denk D, Attarbaschi A et al (2008) Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia. Leukemia 23:134\u2013143","journal-title":"Leukemia"},{"key":"6114_CR3","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","volume":"446","author":"CG Mullighan","year":"2007","unstructured":"Mullighan CG, Goorha S, Radtke I et al (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446:758\u2013764","journal-title":"Nature"},{"key":"6114_CR4","doi-asserted-by":"crossref","unstructured":"Jia Z, Gu Z (2022) PAX5 alterations in B-cell acute lymphoblastic leukemia. Front Oncol; 12","DOI":"10.3389\/fonc.2022.1023606"},{"key":"6114_CR5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","volume":"51","author":"Z Gu","year":"2019","unstructured":"Gu Z, Churchman ML, Roberts KG et al (2019) PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet 51:296\u2013307","journal-title":"Nat Genet"},{"key":"6114_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1053\/j.semdp.2023.04.003","volume":"40","author":"K Davis","year":"2023","unstructured":"Davis K, Sheikh T, Aggarwal N (2023) Emerging molecular subtypes and therapies in acute lymphoblastic leukemia. Semin Diagn Pathol 40:202\u2013215","journal-title":"Semin Diagn Pathol"},{"key":"6114_CR7","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms. Leukemia 36:1720\u20131748","journal-title":"Leukemia"},{"key":"6114_CR8","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP et al (2022) International Consensus classification of myeloid neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140:1200\u20131228","journal-title":"Blood"},{"key":"6114_CR9","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1182\/blood-2009-07-234229","volume":"115","author":"E Coyaud","year":"2010","unstructured":"Coyaud E, Struski S, Prade N et al (2010) Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone De Cytog\u00e9n\u00e9tique H\u00e9matologique study. Blood 115:3089\u20133097","journal-title":"Blood"},{"key":"6114_CR10","doi-asserted-by":"crossref","unstructured":"Shahjahani M, Norozi F, Ahmadzadeh A et al (2014) The role of Pax5 in leukemia: diagnosis and prognosis significance. Med Oncol; 32","DOI":"10.1007\/s12032-014-0360-6"},{"key":"6114_CR11","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/sj.leu.2402923","volume":"17","author":"S Strehl","year":"2003","unstructured":"Strehl S, K\u00f6nig M, Dworzak MN et al (2003) PAX5\/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13). Leukemia 17:1121\u20131123","journal-title":"Leukemia"},{"key":"6114_CR12","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1182\/blood-2014-04-570960","volume":"125","author":"D Schinnerl","year":"2015","unstructured":"Schinnerl D, Fortschegger K, Kauer M et al (2015) The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia. Blood 125:1282\u20131291","journal-title":"Blood"},{"key":"6114_CR13","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1016\/j.leukres.2012.04.015","volume":"36","author":"D Denk","year":"2012","unstructured":"Denk D, Nebral K, Bradtke J et al (2012) PAX5-AUTS2: a recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia. Leuk Res 36:e178\u2013e181","journal-title":"Leuk Res"},{"key":"6114_CR14","doi-asserted-by":"crossref","unstructured":"Anderl S, K\u00f6nig M, Attarbaschi A, Strehl S (2015) PAX5-KIAA1549L: a novel fusion gene in a case of pediatric B-cell precursor acute lymphoblastic leukemia. Mol Cytogenet; 8","DOI":"10.1186\/s13039-015-0138-3"},{"key":"6114_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/bjh.17002","volume":"191","author":"BJ McClure","year":"2020","unstructured":"McClure BJ, Heatley SL, Rehn J et al (2020) High-risk B\u2010cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse. Br J Haematol 191:301\u2013304","journal-title":"Br J Haematol"},{"key":"6114_CR16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s12185-020-02944-4","volume":"112","author":"T Kanayama","year":"2020","unstructured":"Kanayama T, Imamura T, Mayumi A et al (2020) Functional analysis of a novel fusion protein PAX5-KIDINS220 identified in a pediatric Ph-like ALL patient. Int J Hematol 112:714\u2013719","journal-title":"Int J Hematol"},{"key":"6114_CR17","doi-asserted-by":"publisher","first-page":"718","DOI":"10.15252\/embj.201695495","volume":"36","author":"L Smeenk","year":"2017","unstructured":"Smeenk L, Fischer M, Jurado S et al (2017) Molecular role of the PAX5-ETV6 oncoprotein in promoting B\u2010cell acute lymphoblastic leukemia. EMBO J 36:718\u2013735","journal-title":"EMBO J"},{"key":"6114_CR18","first-page":"4666","volume":"61","author":"G Cazzaniga","year":"2001","unstructured":"Cazzaniga G, Daniotti M, Tosi S et al (2001) The paired box domain gene is fused to in an acute lymphoblastic leukemia case. Cancer Res 61:4666\u20134670","journal-title":"Cancer Res"},{"key":"6114_CR19","doi-asserted-by":"crossref","unstructured":"Ma X, Edmonson M, Yergeau D et al (2015) Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat Commun; 6","DOI":"10.1038\/ncomms7604"},{"key":"6114_CR20","doi-asserted-by":"crossref","unstructured":"Lilljebj\u00f6rn H, Henningsson R, Hyrenius-Wittsten A et al (2016) Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat Commun; 7","DOI":"10.1038\/ncomms11790"},{"key":"6114_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1182\/blood.2019002220","volume":"135","author":"BS Li","year":"2020","unstructured":"Li BS, Brady SW, Ma XT et al (2020) Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia. Blood 135:41\u201355","journal-title":"Blood"},{"key":"6114_CR22","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/ajh.26795","volume":"98","author":"A Kwon","year":"2022","unstructured":"Kwon A, Fuda F, Gagan J et al (2022) Rare circulating lymphoblasts with striking eosinophilia: a rare case of B-lymphoblastic leukemia with PAX5::ZCCHC7. Am J Hematol 98:989\u2013990","journal-title":"Am J Hematol"},{"key":"6114_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","volume":"8","author":"Y-F Liu","year":"2016","unstructured":"Liu Y-F, Wang B-Y, Zhang W-N et al (2016) Genomic profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia. EBioMedicine 8:173\u2013183","journal-title":"EBioMedicine"},{"key":"6114_CR24","first-page":"1783","volume":"9","author":"MC Bene","year":"1995","unstructured":"Bene MC, Castoldi G, Knapp W et al (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9:1783\u20131786","journal-title":"Leukemia"},{"key":"6114_CR25","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1038\/leu.2009.135","volume":"23","author":"J Familiades","year":"2009","unstructured":"Familiades J, Bousquet M, Lafage-Pochitaloff M et al (2009) PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study. Leukemia 23:1989\u20131998","journal-title":"Leukemia"},{"key":"6114_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/gcc.22433","volume":"56","author":"K Sakamoto","year":"2016","unstructured":"Sakamoto K, Imamura T, Kanayama T et al (2016) Ph-like acute lymphoblastic leukemia with a novel PAX5\u2010KIDINS220 fusion transcript. Genes Chromosom Cancer 56:278\u2013284","journal-title":"Genes Chromosom Cancer"},{"key":"6114_CR27","doi-asserted-by":"crossref","unstructured":"Fazio G, Bresolin S, Silvestri D et al (2022) PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120. eBioMedicine.; 83","DOI":"10.1016\/j.ebiom.2022.104224"},{"key":"6114_CR28","doi-asserted-by":"crossref","unstructured":"\u010crepin\u0161ek K, Klobu\u010dar N, Tesovnik T et al (2024) PAX5 alterations in a consecutive childhood B-Cell Acute lymphoblastic leukemia cohort treated using the ALL IC-BFM 2009 protocol. Cancers; 16","DOI":"10.3390\/cancers16061164"},{"key":"6114_CR29","doi-asserted-by":"crossref","unstructured":"An Q, Wright SL, Konn ZJ et al (2008) Variable breakpoints target PAX5 in patients with dicentric chromosomes: A model for the basis of unbalanced translocations in cancer. Proceedings of the National Academy of Sciences.; 105: 17050\u201317054","DOI":"10.1073\/pnas.0803494105"},{"key":"6114_CR30","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1038\/s41588-023-01561-1","volume":"55","author":"RJ Leeman-Neill","year":"2023","unstructured":"Leeman-Neill RJ, Song D, Bizarro J et al (2023) Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression. Nat Genet 55:2160\u20132174","journal-title":"Nat Genet"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06114-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-06114-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06114-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:14:56Z","timestamp":1735866896000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-06114-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6114"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-06114-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"assertion":[{"value":"21 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Ethics Committees of Xiangya Hospital and Third Xiangya Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient described.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}